GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system

GE HealthCare (Nasdaq: GEHC) today announced the launch of the new Versana Premier™, the latest release within the Versana ultrasound family of reliable, affordable, easy-to-use, and versatile ultrasound systems. Versana Premier offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy, all while delivering an effortless user experience and helping clinicians best meet their patient needs.i The Versana Premier is designed to meet the multi-purpose needs of healthcare professionals across diverse clinical specialties and care areas, including general practice, OBGYN, musculoskeletal (MSK), and cardiology.

“The rising demand for imaging has driven the increasing use of ultrasound in primary care. Ultrasound is emerging as a key tool in these clinical settings, enabling accelerated diagnoses and improving patient outcomes and satisfaction,” said Phil Rackliffe, president and CEO of Ultrasound and Image Guided Therapies, GE HealthCare. “Versana Premier is equipped with advanced automated workflow and productivity tools, including educational resources, that can support these clinicians who are often the frontline of disease identification and diagnosis for their patients.”

With advanced features that are intuitive and innovative, Versana Premier empowers clinicians to deliver high-quality care and accurately make decisions to reach a diagnosis with the greatest of ease. Powered by VisionBoost Architecture and accompanied by high-quality probes, including XDclear technology, first-class display technology and new imaging engine, Versana Premier provides exceptional image quality with faster speed.ii Users can also optimize images while scanning with Whizz, which continuously optimizes imaging in real time, and adjust color display with Whizz Color Flow. Other features to support clinicians in clinical decisions include OBGYN imaging tools, like Whizz RenderLive and V-Live 2.0, to capture 3D/4D imaging to clearly follow the baby’s development.

With its enhanced ergonomics, automated tools, service and support, the latest release of Versana Premier offers advanced features for simplified diagnostics and guaranteed time savings.iii Clinicians can experience up to a 38% faster workflow with Whizz clinical features available on the system.iii Furthermore, AI-powered Whizz LabeI can automate labeling of the right kidney, gallbladder and liver, and the new Whizz Follicle can assist with volume calculations and measurements.

“Versana Premier is remarkably user-friendly and image quality in B-Mode is easy to optimize, making it possible to create amazing images," said Dr. Martin Altersberger, Director of Echo Laboratory, State Hospital Steyr, Austria. "The ultrasound system integrates advanced functions with optimized image quality and educational resources, which can be used in various settings. It can, therefore, adequately support clinicians in a wide range of assessments and diagnoses.”

Versana Premier is the highest-tier ultrasound system in the budget-friendly Versana ultrasound family, powered with smart clinical features and streamlined workflow tools to enhance efficiency and provide optimal care to a wide range of patients every day – all with effortless productivity in mind. Versana Premier is available in key countries around the globe. In the United States, Versana Premier is 510(k) cleared by the U.S. Food and Drug Administration and is currently commercially available, with shipments beginning later this month. For more information on Versana Premier, visit: .

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on , (formerly Twitter), , , and for the latest news, or visit our website for more information.

i Select features may not be available in all regions

ii Compared to Versana Premier R2

iii GE HealthCare-sponsored usability study, using Whizz. Study was conducted in December 2022. JB24263XX

EN
14/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

Moody's Ratings assigns Baa2 rating to GE HealthCare's senior notes; s...

Moody's Ratings (Moody's) assigned a Baa2 rating to GE HealthCare Technologies Inc.'s (GE HealthCare) proposed offering of senior unsecured notes. There are no changes to GE HealthCare's existing ratings including the Baa2 issuer rating, Baa2 senior unsecured notes ratings and (P)Baa2 senior unsecur...

Moody's Ratings affirms GE HealthCare's Baa2 ratings; outlook stable

Moody's Ratings (Moody's) affirmed the ratings of GE HealthCare Technologies Inc. ("GE HealthCare") including the Baa2 long term issuer rating, Baa2 senior unsecured notes and (P)Baa2 senior unsecured shelf registration. The outlook remains stable. The ratings affirmation reflects GE HealthCare's ...

Moody's Ratings assigns Baa2 rating to GE Healthcare's sr. notes; stab...

Moody's Ratings (Moody's) assigned a Baa2 rating to GE HealthCare Technologies Inc.'s ("GE HealthCare") proposed offering of senior unsecured notes. There are no changes to GE HealthCare's existing ratings including the Baa2 issuer rating, Baa2 senior unsecured notes ratings and (P)Baa2 senior unsec...

 PRESS RELEASE

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

 PRESS RELEASE

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch